Blog
About

5
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Prognosis of Lean and Fat Hypertensives

      , , , ,

      Cardiology

      S. Karger AG

      Lean hypertensives, Fat hypertensives, Mortality, Risk

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A population sample of 1,645 men aged 40–59 at entry examination has been followed up for 25 years. When hypertensives (160 and/or 95 mm Hg or more; n = 432) were divided into fat and lean on the basis of body mass index (cut off at 24.9), the latter group showed a nonsignificant higher risk of dying during the subsequent 25 years (relative risk = 1.15). Univariate and multivariate analyses suggest that among lean people there is an excess of smokers partly explaining the excess risk of lean hypertensives. Both univariate and multivariate analyses also proved that the relationship of fatness-leanness indicators to total mortality is U-shaped and applies to hypertensives as well as to nonhypertensives, and to the whole population. Evidence has been given that changing the definition of fatness-leanness (cutoff of body mass index of 27.9) the relative risk of lean versus fat hypertensives may reverse (0.93). This suggests that a large part of the problem is artificial and should no be tackled without considering the parabolic relationships of indicators of obesity to mortality.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          0008-6312
          1421-9751
          1988
          1988
          11 November 2008
          : 75
          : 6
          : 448-457
          Affiliations
          Laboratory of Epidemiology and Biostatistics, Istituto Superiore di Sanità, Rome, Italy
          Article
          174416 Cardiology 1988;75:448–457
          10.1159/000174416
          3228826
          © 1988 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 10
          Categories
          Prevention

          Comments

          Comment on this article